OncLive | Bringing the Global Oncology Community Together

Selinexor monotherapy induced deep and durable responses in the phase IIb SADAL study of patients with relapsed/refractory diffuse large B-cell lymphoma who are not candidates for autologous stem cell transplantation. Read More >>

TAILORx Analysis Underscores Racial Disparity in Breast Cancer Outcomes

Experts Highlight Developments in Lung, GI Cancers

Direct Targeting of RET Aberrations Moves Closer to the Clinic

Nivolumab Combo Shows Early Activity in Relapsed/Refractory AML

Addressing Off-Target Effects of TKIs in Pediatric CML

View More Stories >>

View Conference Coverage

2018 San Antonio Breast Cancer Symposium

2018 ASH Annual Meeting

2018 Ruesch Center Symposium

2018 Chemotherapy Foundation Symposium

2018 New York Lung Cancers Symposium

Dr. Madduri on Treatment After CAR T Cells in Myeloma

Dr. Vaena on the Importance of Risk Stratification in Prostate Cancer

Dr. Bardia on Potential Concerns With Biosimilars in Breast Cancer

Common Treatment-Related Toxicities in mRCC

Dr. Sabari Compares Liquid and Tissue Biopsies in NSCLC

Dr. Borgen Discusses the Global Impact of Biosimilars

OncLive houses thousands of videos that provide updates and information.
See more Videos

Surgery Options for NSCLC & I-O Therapy in EGFR-Mutations

I-O Options for Stage III NSCLC & International PD-L1 Restrictions

PACIFIC Trial: Positive New Data in OS & PFS

Second-Line after I-O: Where Do We Go from There?

Adjuvant Therapy in Melanoma: COMBI-AD Trial

Molecular Testing for Stage III Melanoma

OncLive houses thousands of videos that provide updates and information.
See more Videos

Other Clinical Trials in Renal Cell Carcinoma

A Novel Approach: TKI/I-O Combinations in RCC

The Workflow of CAR-T Administration

The Logistics of Building a CAR-T Program

Immunotherapy Regimens in dMMR/MSI-High Metastatic CRC

Differentiated Thyroid Cancer: RAI Failure and Survival

OncLive houses thousands of videos that provide updates and information.
See more Videos

Featured

Expert Anticipates Cure in Acute Lymphoblastic Leukemia

Elias Jabbour, MD, discussed recent clinical trial results in acute lymphoblastic leukemia, the role of immunotherapy, and the biggest challenges facing the field.

View more >>>

Featured

Dr. Ramchandren on the North American Results of the ECHELON-1 Study in Hodgkin Lymphoma

Radhakrishnan Ramchandren MD, associate professor, Wayne State University School of Medicine, Barbara Ann Karmanos Cancer Institute, discusses the North American results of the ECHELON-1 study in Hodgkin lymphoma.

View more >>>